These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16684029)

  • 21. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R;
    Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
    Stewart RA; Kerr AJ; Cowan BR; Young AA; Occleshaw C; Richards AM; Edwards C; Whalley GA; Freidlander D; Williams M; Doughty RN; Zeng I; White HD;
    Am Heart J; 2008 Aug; 156(2):348-55. PubMed ID: 18657667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.
    Barnes BJ; Howard PA
    Ann Pharmacother; 2005 Jan; 39(1):68-76. PubMed ID: 15590870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
    Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
    Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
    Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
    Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmogenic difference between the left and right atria in a canine ventricular pacing-induced heart failure model of atrial fibrillation.
    Tai CT; Lo LW; Lin YJ; Chen SA
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):188-95. PubMed ID: 22309251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.
    Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J
    Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
    Nishida K; Chiba K; Iwasaki YK; Katsouras G; Shi YF; Blostein MD; Khairy P; Guerra PG; Dubuc M; Tardif JC; Tanguay JF; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1168-75. PubMed ID: 23095228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
    N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.
    Li D; Fareh S; Leung TK; Nattel S
    Circulation; 1999 Jul; 100(1):87-95. PubMed ID: 10393686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits.
    Laszlo R; Bentz K; Konior A; Eick C; Schreiner B; Kettering K; Schreieck J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):347-56. PubMed ID: 20799026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
    Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
    Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
    J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking aldosterone in heart failure.
    Shafiq MM; Miller AB
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
    Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S
    Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?
    Weir RA; Mark PB; Petrie CJ; Clements S; Steedman T; Ford I; Ng LL; Squire IB; Wagner GS; McMurray JJ; Dargie HJ
    Am Heart J; 2009 Jun; 157(6):1088-96. PubMed ID: 19464421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective aldosterone blockade with eplerenone in patients with congestive heart failure.
    Salam AM
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1423-7. PubMed ID: 12882627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.